Resumes
Resumes
Glenn Pilkington Phones & Addresses
-
13 Lilly Ln, San Carlos, CA 94070 (650) 593-7499
-
Issaquah, WA
-
1790 Nantucket Cir, Santa Clara, CA 95054
-
10488 Parthenon Ct, Bethesda, MD 20817 (301) 767-3998 (301) 770-3313
-
Renton, WA
-
San Mateo, CA
-
Newton, MA
-
Rockville, MD
Work
Position:
Food Preparation and Serving Related Occupations
Education
Degree:
High school graduate or higher
Publications
Us Patents
Neutralizing Monoclonal Antibodies To Respiratory Syncytial Virus
View pageUS Patent:
8221759, Jul 17, 2012
Filed:
Sep 30, 2011
Appl. No.:
13/250357
Inventors:
Glenn R. Pilkington - Bethesda MD, US
Page S. Gilmour - Rockville MD, US
Robert M. Chanock - Betheseda MD, US
Brian R. Murphy - Bethesda MD, US
Page S. Gilmour - Rockville MD, US
Robert M. Chanock - Betheseda MD, US
Brian R. Murphy - Bethesda MD, US
Assignee:
Intracel Resources LLC - Frederick MD
International Classification:
A61K 39/42
US Classification:
4241471, 4241331, 4241351, 4241411, 5303881, 5303882, 5303883
Abstract:
The present invention relates to the identification and cloning of a novel neutralizing human monoclonal antibody to the Respiratory Syncytial Virus. The invention provides such antibodies, fragments of such antibodies retaining RSV-binding ability, chimeric antibodies retaining RSV-binding ability, and pharmaceutical compositions including such antibodies. The invention further provides for isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith. Finally, the invention provides for diagnostic and therapeutic methods employing the antibodies and nucleic acids of the invention.
Neutralizing Monoclonal Antibodies To Respiratory Syncytial Virus
View pageUS Patent:
20040005324, Jan 8, 2004
Filed:
Apr 30, 2003
Appl. No.:
10/425855
Inventors:
Glenn Pilkington - Bethesda MD, US
Page Gilmour - Rockville MD, US
Robert Chanock - Bethesda MD, US
James Crowe - Brentwood TN, US
Brian Murphy - Bethesda MD, US
Page Gilmour - Rockville MD, US
Robert Chanock - Bethesda MD, US
James Crowe - Brentwood TN, US
Brian Murphy - Bethesda MD, US
International Classification:
A61K039/42
C07K016/10
C07K016/10
US Classification:
424/159100, 530/388300
Abstract:
The present invention relates to the identification and cloning of a novel neutralizing human monoclonal antibody to the Respiratory Syncytial Virus. The invention provides such antibodies, fragments of such antibodies retaining RSV-binding ability, chimeric antibodies retaining RSV-binding ability, and pharmaceutical compositions including such antibodies. The invention further provides for isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith. Finally, the invention provides for diagnostic and therapeutic methods employing the antibodies and nucleic acids of the invention.
Neutralizing Monoclonal Antibodies To Respiratory Syncytial Virus
View pageUS Patent:
20090110684, Apr 30, 2009
Filed:
Apr 24, 2008
Appl. No.:
12/082000
Inventors:
Glenn R. Pilkington - Bethesda MD, US
Page S. Gilmour - Rockville MD, US
Robert M. Chanock - Bethesda MD, US
Brian R. Murphy - Bethesda MD, US
Page S. Gilmour - Rockville MD, US
Robert M. Chanock - Bethesda MD, US
Brian R. Murphy - Bethesda MD, US
International Classification:
A61K 39/395
A61K 31/7088
A61P 31/12
A61K 31/7088
A61P 31/12
US Classification:
4241591, 514 44
Abstract:
The present invention relates to the identification and cloning of a novel neutralizing human monoclonal antibody to the Respiratory Syncytial Virus. The invention provides such antibodies, fragments of such antibodies retaining RSV-binding ability, chimeric antibodies retaining RSV-binding ability, and pharmaceutical compositions including such antibodies. The invention further provides for isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith. Finally, the invention provides for diagnostic and therapeutic methods employing the antibodies and nucleic acids of the invention.